...
首页> 外文期刊>Transfusion medicine >Multiplex polymerase chain reaction with DNA pooling: A cost-effective strategy of genotyping rare blood types
【24h】

Multiplex polymerase chain reaction with DNA pooling: A cost-effective strategy of genotyping rare blood types

机译:具有DNA池的多重聚合酶链反应:基因型罕见血型的高性价比策略

获取原文
获取原文并翻译 | 示例

摘要

Objectives/Aims: This work aims to develop a multiplex polymerase chain reaction combined with DNA pooling for mass screening for rare blood types. Background: The differences in most blood group antigens are associated with single-nucleotide polymorphisms (SNPs), which are used in detecting blood antigen expression at the molecular level. However, all existing sequence-specific primers polymerase chain reaction (PCR-SSP) assays for blood typing genotype one or several SNPs individually. DNA pooling is a way that reduces the amount of genotyping required. Methods: A sensitive multiplex PCR-SSP assay testing pooled DNA was established to detect the rare Fyb and S alleles. It was applied to screen a total of 4490 donor samples via testing 898 DNA pools. The samples in the positive pools were further tested individually. Then the positive samples, including Fy(a-b+)/Fy(a+b+) and S+s-/S+s+ genotypes, were tested via two PCR-SSP assays for alleles Fya and s. The rare genotypes Fy(a-b+) and S+s- were verified using serologic tests and sequencing analysis. Results: Two hundred and fifty-four donors were tested positive for the Fyb allele, whereas 101 donors were positive for the S allele. Among the 254 Fy(b+) donors, 5 were Fy(a-b+) and 249 were Fy(a+b+). Among the 101 S+ donors, 3 were S+s- and 98 were S+s+. The rare Fyb and S alleles comprised 2·28 and 1·16%, respectively. The PCR-SSP assays were confirmed by sequencing analysis and serological test. Conclusion: A multiplex PCR assay was combined with DNA pooling to reduce the number of tests required, making large-scale screening feasible.
机译:目的/目的:这项工作旨在开发一种多重聚合酶链反应与DNA池相结合,以对稀有血液类型进行大规模筛查。背景:大多数血型抗原的差异与单核苷酸多态性(SNP)有关,后者用于从分子水平检测血液抗原的表达。但是,所有现有的针对血液分型基因型一或多个SNP的序列特异性引物聚合酶链反应(PCR-SSP)分析方法均适用。 DNA合并是减少所需基因分型数量的一种方法。方法:建立灵敏的多重PCR-SSP法检测合并的DNA,以检测罕见的Fyb和S等位基因。通过测试898个DNA库,将其用于筛选总共4490个供体样品。阳性池中的样品将单独进行进一步测试。然后,通过两个PCR-SSP分析检测等位基因Fya和s的阳性样品,包括Fy(a-b +)/ Fy(a + b +)和S + s- / S + s +基因型。罕见的基因型Fy(a-b +)和S + s-使用血清学检测和测序分析进行了验证。结果:254个供体的Fyb等位基因为阳性,而101个供体的S等位基因为阳性。在254位Fy(b +)供体中,有5位是Fy(a-b +),有249位是Fy(a + b +)。在101个S +供体中,有3个是S + s-,有98个是S + s +。罕见的Fyb和S等位基因分别占2·28和1·16%。通过测序分析和血清学测试确认了PCR-SSP测定。结论:多重PCR分析与DNA合并相结合,减少了所需的检测数量,使大规模筛选成为可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号